Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...
See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
What Medications Cause Tardive Dyskinesia? - Verywell Health
Dec 8, 2025 · Tardive dyskinesia is a side effect that causes uncontrollable, repetitive body movements. It is caused by long-term use of antipsychotic medications.
Pharmacology Vesicular monoamine transporter 2 (VMAT2) is a protein that regulates the packaging and release of monoamines (dopamine, serotonin, norepinephrine, and histamine). …
Austedo XR Approved: A New Treatment Option for Tardive ...
May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
Treatments – National Organization for Tardive Dyskinesia
While the recommendations in the above table can prove effective for many individuals with TD, there have been numerous additional treatments studied to determine their effectiveness in …
FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine ...
May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia …
Deutetrabenazine - Wikipedia
Deutetrabenazine, sold under the brand name Austedo, is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's disease and …
Patients Taking AUSTEDO XR® (deutetrabenazine) - GlobeNewswire
Sep 21, 2025 · Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine)...